These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5816419)

  • 41. [Current trends in the use of combined serum and vaccine in tetanus prevention].
    Olivo R; Fabio U
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization aginast tetanus with aluminium free-versus aluminium contain triple vaccine.
    Ullberg-Olsson K; Wickbom B; Eriksson E
    Dev Biol Stand; 1979; 43():39-41. PubMed ID: 520684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Active-passive immunization of human subjects against tetanus using homologous gamma globulin.
    Matveev KI; Skurkovich SV; Bychenko BD; Kasparova EM; Konstantinova ND; Minaeva HL
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):246-51. PubMed ID: 4137523
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevention of tetanus in the wounded.
    Laurence DR; Evans DG; Smith JW
    Br Med J; 1966 Jan; 1(5478):33-4. PubMed ID: 5900904
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical tetanus despite a protective level of toxin-neutralizing antibody.
    Passen EL; Andersen BR
    JAMA; 1986 Mar; 255(9):1171-3. PubMed ID: 2868135
    [No Abstract]   [Full Text] [Related]  

  • 46. [Recurrent tetanus. Clinical, immunological and therapeutic considerations].
    Warter J; Mantz JM; Tempe JD; Otteni JC
    Presse Med (1893); 1967 May; 75(24):1223-6. PubMed ID: 6024174
    [No Abstract]   [Full Text] [Related]  

  • 47. Problems in the immunology and control of tetanus.
    Edsall G
    Med J Aust; 1976 Aug; 2(6):216-20. PubMed ID: 979853
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral immunization against tetanus.
    Baljer G
    Dev Biol Stand; 1976; 33():63-71. PubMed ID: 955281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Editorial: The inexcusable disease.
    Edsall G
    JAMA; 1976 Jan; 235(1):62-3. PubMed ID: 946007
    [No Abstract]   [Full Text] [Related]  

  • 50. Combined active-passive immunization against tetanus in man.
    Mahoney LJ; Aprile MA; Moloney PJ
    Can Med Assoc J; 1967 May; 96(21):1401-4. PubMed ID: 6026992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PASSIVE IMMUNIZATION AGAINST TETANUS: SOME OBSERVATIONS ON THE USE AND REACTIVITY OF HETEROLOGOUS ANTITOXINS.
    TRINCA JC
    Med J Aust; 1965 Jul; 2(3):113-5. PubMed ID: 14333767
    [No Abstract]   [Full Text] [Related]  

  • 52. [Local reactions after repeated tetanus vaccinations].
    Wegmann A; Heiz R
    Schweiz Med Wochenschr; 1979 Oct; 109(38):1409-10. PubMed ID: 531542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A model for developing countries of mass serological survey of children vaccinated against diphtheria and tetanus.
    Nazari F; Mirchamsy H; Alé-Agha S; Mahinpour M
    J Biol Stand; 1976; 4(4):329-35. PubMed ID: 993218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tetanus or drug reaction?
    Mackler S; Moskowitz M
    Hosp Pract (Off Ed); 1989 Aug; 24(8):75-8, 81-2, 85-9. PubMed ID: 2504742
    [No Abstract]   [Full Text] [Related]  

  • 55. Response to single dose of tetanus vaccine in subjects with naturally acquired tetanus antitoxin.
    Dastur FD; Awatramani VP; Dixit SK; D'Sa JA; Cooverji ND; Anand MP
    Lancet; 1981 Aug; 2(8240):219-22. PubMed ID: 6114281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experimental investigations on oral immunization with tetanus-toxoid (author's transl)].
    Baljer G; Starflinger H; Sorg KH; Sailer J; Mayr A
    Zentralbl Bakteriol Orig A; 1975 Aug; 232(4):488-98. PubMed ID: 1199521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Local reactions and antitoxin circulating levels induced by the administration of tetanus toxoid. Comparative study between Ped-o-Jet and hypodermic syringe].
    Pluciennik AM; de Rizzo E; Higashi HG; Konishi CK; Freitas ES; Veneziani P; Takabayashi Y; da Silveira EE
    Rev Saude Publica; 1985 Jun; 19(3):201-14. PubMed ID: 4095478
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immune status after tetanus vaccination. Possibilities and indications for a quantitative rapid determination of tetanus antibodies in human serum].
    Holzner A
    Fortschr Med; 1978 Apr; 96(13):680-3. PubMed ID: 631708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination.
    Simonsen O; Badsberg JH; Kjeldsen K; Møller-Madsen B; Heron I
    Acta Pathol Microbiol Immunol Scand C; 1986 Apr; 94(2):77-82. PubMed ID: 3739720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effectiveness of tetanus vaccination in an adult population 10 years after the last dose].
    Palomo Cobos L
    Aten Primaria; 1994 Sep; 14(4):707-10. PubMed ID: 7803675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.